Hossein Najmabadi - Genetic Mutations

Author Information

Hossein Najmabadi is a distinguished researcher affiliated with the Genetics Research Centre at the University of Social Welfare and Rehabilitation Sciences in Tehran, Iran. He is also associated with the Kariminejad-Najmabadi Pathology & Genetics Center in Tehran. Najmabadi's work is primarily focused on the field of genetics, with a significant emphasis on understanding genetic disorders and their molecular bases.

Research Contributions

Hossein Najmabadi has made substantial contributions to genetics research, particularly in the context of genetic disorders. His recent work includes studies on the genetic etiology of hearing loss in Iran, the molecular basis of Fragile X Syndrome, and the role of ZBTB11 dysfunction in brain abnormalities. Najmabadi has also investigated the impact of genetic variations on conditions such as intellectual disability and schizophrenia, contributing to a deeper understanding of these complex disorders.

Aliases

Hossein Najmabadi is known by several aliases in his academic publications, including "H Najmabadi" and "H. Najmabadi." These variations are used interchangeably across his papers.

Publication and Citation Metrics

Metric	Value
Citation Count	10,747
h-index	53
Paper Count	419

Publications:

The Effect of Xmn -1 Polymorphism and Coinheritance of Alpha Mutations on Age at First Blood Transfusion in Iranian Patients with Homozygote IVSI-5 Mutation

DOI: 10.18502/ijhoscr.v16i1.8441

Year: 2022

ZBTB11 dysfunction: spectrum of brain abnormalities, biochemical signature and cellular consequences.

DOI: 10.1093/brain/awac034

Year: 2022

Genetic etiology of hearing loss in Iran

DOI: 10.1007/s00439-021-02421-w

Year: 2022

DNA Banking to Assess Genetic Influences on Schizophrenia

DOI: 10.47176/mjiri.36.42

Year: 2022

Intellectual disability associated with craniofacial dysmorphism due to POLR3B mutation and defect in spliceosomal machinery

DOI: 10.1186/s12920-022-01237-5

Year: 2022

Phenotype and genotype spectrum of variants in guanine nucleotide exchange factor genes in a broad cohort of Iranian patients

DOI: 10.1002/mgg3.1894

Year: 2022

Identification of microRNAs associated with human fragile X syndrome using next-generation sequencing

DOI: 10.1038/s41598-022-08916-4

Year: 2022

Understanding the Molecular Basis of Fragile X Syndrome Using Differentiated Mesenchymal Stem Cells

DOI: 10.22037/ijcn.v15i4.22070

Year: 2022

Biallelic mutations in the death domain of PIDD1 impair caspase-2 activation and are associated with intellectual disability

DOI: 10.1038/s41398-020-01158-w

Year: 2021

Identification of microRNAs Associated With Human Fragile X Syndrome Using Next Generation Sequencing

DOI: 10.21203/RS.3.RS-523429/V1

Year: 2021

What Types of Radiation Are Most Harmful?

What Preventive Measures Can Be Taken?

What are Non-Coding Regions?

What is Meiosis?

How do PAHs cause genetic mutations?

Which Gene is Involved?

How does Pharmacogenomics Relate to Genetic Mutations?

What Are the Treatment Options?

How Do Genetic Mutations Affect Immunotherapy?

What is the CFTR Gene?

Partnered Content Networks

Relevant Topics